# Clazakizumab: A Therapeutic Approach for Patients With Late Antibody-Mediated Rejection

**Authors:** Stanley C. Jordan

PMC · DOI: 10.1016/j.ekir.2025.09.040 · Kidney International Reports · 2025-10-08

## Full-text entities

- **Chemicals:** Clazakizumab (MESH:C000604955)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12640071/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12640071/full.md

---
Source: https://tomesphere.com/paper/PMC12640071